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Introduction
The ability to move in response to a stimulus is a fundamental
property of animal cells. Cell motility is essential for
embryological development and is also required for normal
physiology in the adult, as it contributes to wound healing,
axonal extension and the immune response. Although the
precise molecular mechanisms that control cell motility are not
completely understood, it appears to be a complex process that
requires the simultaneous assembly of branched, rapidly
growing actin arrays to move the leading edge forward by
protrusion, and of contractile actin arrays in the body of cell to
allow the rest of the cell to follow the leading edge (reviewed
in Pollard and Borisy, 2003; Krause et al., 2003; Raftopoulou
and Hall, 2004). In addition, the cell must coordinate the
assembly of new focal adhesions at the front of the cell and
detachment of focal adhesions at the rear of the cell. Thus, in
order for a cell to move normally, the organization of
functionally distinct actin-based structures must be coordinated
both spatially and temporally with remarkable precision.
Multiple actin-binding proteins contribute to this process, and
the task of recruiting actin-binding proteins to specific
subcellular locations is performed by cytoskeletal scaffolds.
Lasp-1 is a multi-domain, actin-associated protein that
possesses the key features of a cytoskeletal scaffold. Lasp-1
contains a variety of conserved domains that function as
protein-interaction sites: an N-terminal LIM domain, followed
by an actin-binding nebulin repeat and a C-terminal SH3
domain. Several lines of evidence suggest that Lasp-1 plays an
important role in the cytoskeletal changes that drive cell
migration. First, Lasp-1 was originally cloned from a cDNA
library derived from metastatic breast cancer and is
overexpressed in many breast tumors, suggesting that it may
be involved in the abnormal motility that is characteristic of
metastatic cells (Tomasetto et al., 1995; Bieche et al., 1996).
Second, Lasp-1 binds directly to actin and is concentrated in
actin-rich structures that are required for motility, including
focal adhesions and lamellipodia (Schreiber et al., 1998; Chew
et al., 2002; Lin et al., 2004), and in the motile growth cones
of cultured neurons (Phillips et al., 2004). Third, a recent study
demonstrated that either depletion of Lasp-1 by RNAi
technology or overexpression of Lasp-1 by transient
transfection disrupts the ability of cultured cells to migrate in
a chemotaxis assay (Lin et al., 2004). It appears that in order
for a cell to migrate normally, the amount of Lasp-1 within the
cell must be maintained within precise limits.
Palladin is a recently described, multi-domain protein that
also appears to function as a potent cytoskeletal scaffold.
Similar to Lasp-1, palladin is a phosphoprotein that localizes
to actin-rich structures and focal adhesions (Parast and Otey,
2000). Depletion of palladin from a variety of cultured cells
(including fibroblasts, neurons and trophoblasts) results in a
dramatic loss of actin organization and gross disruptions in cell
Palladin is a recently described phosphoprotein with an
important role in cytoskeletal organization. The major
palladin isoform (90-92 kDa) binds to three actin-
associated proteins (ezrin, VASP and -actinin), suggesting
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similar localization pattern to 90 kDa palladin.
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directly to the SH3-domain protein Lasp-1. Binding of 140
kDa palladin, but not 90 kDa palladin, to Lasp-1 was
confirmed by yeast two-hybrid and GST-pull-down assays.
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fibers. These results add Lasp-1, an actin-binding protein
with a crucial role in cell motility, to the growing list of
palladin’s binding partners, and suggest that 140 kDa
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arrays that participate in cell migration and/or cellular
contractility.
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morphology, suggesting that palladin plays an important role
in the maintenance of a normal actin cytoskeleton (Parast and
Otey, 2000; Boukhelifa et al., 2001). Palladin expression is also
required for normal mammalian embryogenesis, because a
palladin knockout mouse was shown to have an embryonic
lethal phenotype (Luo et al., 2005). Palladin belongs to a
family of proteins, all of which bind to -actinin (reviewed in
Otey and Carpen, 2004). The two other family members,
myotilin and myopalladin, are both expressed in striated
muscle and localize to the Z-disc (Salmikangas et al., 1999;
Bang et al., 2001). Mutations in the myotilin gene have been
implicated in a human limb girdle muscular dystrophy,
indicating that this family member is required for the
maintenance of a normal, functional sarcomeric cytoskeleton
(Hauser et al., 2000; Hauser et al., 2002; Salmikangas et al.,
2003). The third family member, myopalladin, binds to nebulin
(in skeletal muscle) and nebulette (in cardiac muscle), and
might have a crucial function in linking these cytoskeletal
proteins to the Z-line (Bang et al., 2001; Ma and Wang, 2002).
Thus, all three family members appear to play important roles
in the assembly of specialized actin arrays, and in the
maintenance of normal cell morphology.
Unlike myopalladin and myotilin, palladin is widely
expressed in developing mouse tissues. It has been reported
that a single palladin gene gives rise to multiple size variants,
some of which are expressed in tissue-specific patterns (Parast
and Otey, 2000; Mykkanen, 2001). The most common palladin
isoform in mouse runs as a closely spaced doublet at 90-92
kDa (Parast and Otey, 2000). A 140 kDa isoform is also widely
expressed and was observed to be particularly abundant in
epithelial-derived cell lines, whereas a 200 kDa isoform was
detected in heart (Parast and Otey, 2000). The tissue-specific
expression pattern of palladin isoforms suggests that they
contribute to the acquisition of distinct cell morphologies. In
the current study, we set out to identify and characterize the
larger isoforms of palladin in the mouse, and to understand how
their molecular structure differs from that of the ubiquitous 90-
92 kDa isoform. In addition, we report here that the 140 kDa
isoform of palladin binds directly to Lasp-1 and, thus, might
be involved in recruiting Lasp-1 to specific subcellular
locations. In support of this, we observe that knockdown of the
140 kDa isoform of palladin results in diminished localization
of Lasp-1 to bundled F-actin in HeLa cells.
Results
Palladin isoforms were identified in silico
Subsequent to the publication of the original papers describing
palladin (Parast and Otey, 2000; Mykkanen et al., 2001), a
large amount of nucleotide sequence was added to genome and
transcriptome databases (Lennon et al., 1996; Okazaki et al.,
2002). Initially, palladin was identified from -phage and yeast
two-hybrid clones of the predominant 90-92 kDa isoform and
as a partial clone of the 140 kDa isoform. Since we were aware
of the expression of additional isoforms, we searched
NCBI/GenBank nucleotide databases for new transcripts and
identified multiple cDNA entries. These nucleotide sequences
made it possible to determine the peptide sequences of the 140
kDa and 200 kDa isoforms that had previously been identified
by western blot. The coding sequences of the 140 kDa and 200
kDa isoforms are best represented by GenBank cDNA
accession numbers AK173081 and AK052489, respectively.
As shown in Fig. 1D, these isoforms are essentially N-terminal
extensions of the 90 kDa protein. The extended N-terminal
sequence of 140 kDa palladin is proline-rich (~14% proline)
and contains two additional putative binding sites for members
of the Ena/Mena/VASP protein family. It also encodes a fourth
IgC2 domain. The 200 kDa isoform contains this same N-
terminal sequence, but is extended by a further 389 amino
acids. This additional sequence includes a fifth IgC2 domain
and a large span of sequence that does not appear to fall into
any recognizable domain class by primary sequence analysis.
The IgC2-domain organization and sequence of the 200 kDa
palladin isoform shares very strong homology with the recently
described protein myopalladin, suggesting that divergence of
myopalladin and palladin arose from genetic duplication.
Sequence alignment of myopalladin and 200 kDa palladin is
shown in supplementary material Fig. S1. Two smaller mouse
isoforms were also identified in the transcriptome databases.
The coding sequence of 90 kDa palladin was originally
identified by using BLAST to search the GenBank database
with a partial -phage clone (Parast and Otey, 2000). This first
partial clone had been originally identified by virtue of its
reactivity with palladin antibodies. Its partial sequence was
extended 5 by using BLAST to compare it against the
databases to reveal a putative start codon. This revealed the
transcription of an apparent full-length sequence in murine
heart (GenBank accession number AA671190) that was
expected to result in expression of a protein with molecular
mass that approximates the apparent SDS-PAGE mass of the
90 kDa isoform. However, during the genetic analysis of
palladin isoforms, it became apparent that the initial discovery
of murine palladin was based on the identification of a partial
transcript of the 140 kDa or 200 kDa isoforms (GenBank
accession number AF205079). Since the 90 kDa coding
sequence is wholly contained within these larger transcripts, it
was initially believed that this sequence corresponded to the
predominant 90 kDa isoform. However, we now realize that the
90 kDa isoform begins with the peptide sequence MSALA, 126
amino acids downstream of the start site originally identified.
The 90 kDa transcript was identified in the human
transcriptome (GenBank accession number AB023209) and a
partial transcript was identified in the murine transcriptome
(GenBank accession number BQ927960). Despite this
amended understanding of the 90 kDa palladin sequence, it is
not necessary to revise past characterizations of 90 kDa
isoform’s activities, because all protein interactions that had
been previously characterized are retained in this amended
sequence, as shown in Fig. 1D. However, rather than
containing two Ena/VASP-binding motifs, it is now recognized
that the 90 kDa isoform contains only one.
Transcription is initiated from one of three sites within
the palladin gene
The murine palladin gene (Palld) spans approximately 390 kbp
on chromosome 8 and comprises at least 24 exons. Three of
these exons, respectively the first, third and twelfth  are 5
noncoding exons that are specific for one of three possible
transcription start sites. Analysis of the 5 untranslated regions
of 90 kDa, 140 kDa and 200 kDa transcripts reveals that
although these mRNAs are transcribed from a single locus,
their expression is under the control of three independent
promoters nested within the murine gene, as shown in Fig. 1A.
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The 200 kDa transcript is transcribed from a distal 5 promoter,
whereas the 140 kDa transcript is initiated at a promoter 140
kb downstream. The predominant 90 kDa transcript is initiated
at the most 3 promoter, which lies approximately 340 kb
downstream of the 200 kDa promoter. The sequences of the
palladin exons and their splice sites are provided in the
supplementary material Table S1.
Full-length murine cDNA sequences have also provided
strong evidence for the existence of other palladin isoforms that
utilize alternative splicing or termination mechanisms. A
fourth isoform, ‘C-terminus’, is putatively expressed as the C-
terminal sequence common to the 90 kDa, 140 kDa and 200
kDa isoforms. This transcript of this isoform results from
initiation at the 90 kDa promoter and the utilization of an
alternative splice site within this transcript’s second exon and
the gene’s thirteenth (represented by GenBank accession
number AK087270). A recent paper describing a paladin-
knockout mouse provides evidence for the expression of this
C-terminal isoform and shows it to migrate with an apparent
molecular mass of about 50 kDa, which approximates its
predicted size (Luo et al., 2005). This splicing event appears
to be more common in human cells, in which this exon is
skipped in transcripts initiated at all three promoters (accession
numbers NM016081, AK095512 and AF151909). A fifth
isoform is putatively expressed as the N-terminal extension of
the 140 kDa isoform. This  transcript of this isoform results
from initiation at the 140 kDa promoter and the ostensible
utilization of alternative termination and polyadenylation
signals upstream of the 90 kDa promoter (represented by
GenBank accession number AK087573). The expression of the
N-terminus isoform remains yet unconfirmed. Because these
smaller isoforms lack the epitopes detected by monoclonal
antibodies used in the initial characterization of palladin, they
were not previously detected in cells or tissues.
The 140 kDa isoform is widely
expressed in developing tissues
Earlier studies of palladin have focused
on the 90 kDa isoform. We undertook to
explore the tissue distribution of the 140
kDa and 200 kDa isoforms more
carefully. A new polyclonal antibody
was generated, using a fragment
encoding the N-terminal extension of
the 140 kDa isoform as an immunogen.
Fig. 1. Multiple palladin isoforms are
transcribed from one gene. (A) Schematic
representation of the gene structure of
palladin . The murine palladin gene
comprises at least 24 exons over ~390 kb on
chromosome 8 (Palld; cytoband B3.1).
Transcripts are initiated from one of three
nested promoters, which are indicated with
arrowheads. (B) Schematic representation of
the largest palladin isoform (200 kDa),
which is transcribed from the most 5
promoter. The two proline-rich regions have
been designated PR1 and PR2.
(C) Schematic representation of mRNA
splicing patterns for observed isoforms.
Translation initiation and termination sites
have been aligned with the above peptide
sequence for the 200 kDa isoform.
(D) Schematic representation of palladin
isoforms. The 200 kDa, 140 kDa and 90
kDa isoforms are the primary products of
the palladin gene and have been detected by
immunoblotting. They share binding
sequences for ezrin, -actinin, Ena/VASP
family members and profilin. The 140 kDa
and 200 kDa isoforms also encode two
additional FPPPP motifs predicted to
interact with Ena/VASP family members.
Two other murine isoforms, designated N-
terminus and C-terminus, have been
reported at the cDNA level. Expression of













This antibody recognizes the 140 kDa and 200 kDa palladin
isoforms but not the 90 kDa isoform. Although sequence
homology between palladin and myopalladin is strong in this
region, no crossreactivity to myopalladin was observed (data
are shown in supplementary material, Fig. S2). As shown in
Fig. 2A, immunoblot analysis shows that the 140 kDa isoform
is widely expressed in neonatal tissues (postnatal day 1),
because it was detected in brain, heart, lung, stomach, intestine,
kidney, bone and skin. In late development, the expression of
the 140 kDa isoform is downregulated in many tissues. By
adulthood, expression of the 140 kDa isoform is restricted to
cardiac muscle and to organs rich in smooth muscle (Fig. 2B).
The 90 kDa isoform is a phosphoprotein (Parast and Otey,
2000), and the observation of the 140 kDa isoform as a doublet
suggests that it is also phosphorylated. The 200 kDa isoform,
unlike the 90 kDa and 140 kDa isoforms, is highly restricted
in its expression. In neonatal tissues, the 200 kDa isoform is
detected only in striated muscle and bone. The 200 kDa
isoform remains highly expressed in skeletal and cardiac
muscle of adult mice, where it might play a role similar to
myopalladin in the organization of thin filaments in the Z-line
of sarcomeres. The detection of a band slightly below the
predominant 200 kDa band in heart (Fig. 2A, lane 2) may
represent post translational modification of this isoform, or
alternatively, may be a yet unidentified splice variant.
The 90 kDa and 140 kDa isoform colocalize
To study the 140 kDa isoform of palladin in more detail, the
full-length coding sequence was cloned from a primary culture
of mouse astrocytes. Vector-driven expression of this myc-
tagged sequence in mammalian cells confirmed that in SDS-
PAGE it migrates with the same apparent molecular mass as
the endogenous protein (Fig. 2C). In addition, sequencing of
the 140 kDa palladin cDNA confirmed published database
entries. Since many tissues express both the 140 kDa and 90
kDa isoforms of palladin, it was of interest to determine
whether these isoforms are specialized for different functions.
To explore this possibility, we first asked whether these two
isoforms differ in their subcellular localization patterns. For
this purpose we chose to use primary cultures of rat astrocytes
because both the 140 kDa and 90 kDa isoforms are highly
expressed in these cells (Fig. 2C). The a-4IgNT polyclonal
antibody was used to specifically detect the 140 kDa isoform
by immunocytochemistry (Fig. 3A-C). To specifically localize
the 90 kDa isoform in these cells, it was necessary to express
myc-tagged palladin, because it is not possible to use an
antibody to detect exclusively the endogenous 90 kDa isoform.
Accordingly, cells were infected with adenovirus expressing
the 90 kDa sequence with an N-terminal myc-epitope tag,
incubated for 12 hours, fixed and stained with a monoclonal
anti-myc antibody to detect the exogenous 90 kDa palladin.
Immunostaining of subconfluent cultures demonstrates that the
90 kDa and the 140 kDa isoforms colocalize with an extremely
high coincidence (Fig. 3). Both isoforms mainly localize in a
punctate pattern along stress fibers (Fig. 3B,E) and in nodes
between bundled F-actin arranged in a geodesic pattern (Fig.
3A,D). An interesting feature of astrocytic cultures is that the
morphology of the cells changes from fibroblastic to epithelial
when the cultures are maintained at high-density for two weeks
or more. In these ‘long-term’ cultures, both the 90 kDa and 140
kDa isoforms localize to cell-to-cell junctions (Fig. 3C,F).
Overexpression of palladin isoforms results in distinctive
cytoskeletal phenotypes
We went on to ask whether the 90 kDa and 140 kDa isoforms
of palladin exhibit functional differences at the molecular level.
Previous results have shown that overexpression of 90 kDa
palladin in cultured astrocytes or COS-7 cells results in the
Journal of Cell Science 119 (6)
Fig. 2. Immunoblot of larger palladin isoforms. (A) Tissues were
dissected from a neonatal mouse and immunoblotted with the
polyclonal antibody a-4IgNT that detects the N-terminal extension of
the 200 kDa and 140 kDa palladin isoforms. This antibody does not
crossreact with the 90 kDa isoform. Similar to the reported
expression of the 90 kDa isoform, the 140 kDa isoform of palladin is
expressed in most neonatal mouse tissues, whereas the 200 kDa
isoform is predominantly restricted to heart, muscle and bone.
(B) The 140 kDa isoform is considerately downregulated in many
adult tissues, but is abundant in tissues rich in smooth muscle, such
as stomach and uterus. The 200 kDa isoform is expressed in striated
muscle of the adult mouse. (C) Vector-driven expression of the
putative 140 kDa palladin nucleotide sequence in COS-7 cells results
in the translation of an immunoreactive band with the same apparent
molecular mass observed for endogenous protein in astrocytes.
Astrocytes express relatively high levels of the 140 kDa isoform of
palladin. Immunodetection with a previously characterized
monoclonal (left blot) that reacts with the 90 kDa, 140 kDa and 200
kDa isoforms demonstrates that the 90 kDa and 140 kDa isoforms
are expressed in cultured astrocytes. The polyclonal antibody a-
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formation of unusual, extra-thick actin bundles (Boukhelifa et
al., 2003; Rönty et al., 2004). To compare the overexpression
phenotypes of the 90 kDa and 140 kDa isoforms of palladin,
myc-tagged versions were transfected into COS-7 cells.
Twenty-four hours after transfection, expression of the 90 kDa
isoform induced dramatic bundling of F-actin. In most of these
cells, the actin bundles were arranged in a parallel fashion (Fig.
4Ai,Bi) and appeared to be anchored at focal adhesions (data
not shown). Expression of the 140 kDa isoform resulted in
dramatic actin reorganization in all transfected cells, but by
contrast, F-actin was frequently organized in a star-like pattern
exhibiting a pronounced radial symmetry and significant
compaction (Fig. 4Aiv,Bii). To quantify the distinct phenotypes
resulting from overexpression of 90 kDa and 140 kDa palladin,
100 cells were scored blindly for each transfection. All cells
that expressed exogenous protein at detectable levels exhibited
significant rearrangements of actin, and these were grouped
into one of three categories: star-like, large bundles and small
bundles. Star-like assemblies were classified by both radial
symmetry and a diameter that did not exceed 20 m. Large
and small bundles were more arbitrarily distinguished by the
extent of bundling within the cell and the reduction of
background fluorescence from nonbundled filaments.
Examples of large and small bundles are provided in
supplementary material Fig. 2. Out of 100 cells transfected
with the 140 kDa isoform, 46 formed star-like patterns, 46
formed large bundles and eight formed small bundles (Fig. 4C).
Most cells with star-like assemblies contained two of them, but
a range of 1-6 star-like arrangements per cell was observed.
Out of 100 cells counted that were transfected with the 90 kDa
Fig. 3. Immunolocalization of palladin
isoforms in cultured astrocytes. The
myc-tagged, 90 kDa isoform of palladin
was transfected into embryonic rat
astrocytes with adenovirus.
(D-F) Expressed 90 kDa palladin was
detected 12 hours later with a
monoclonal antibody directed against
the N-terminal myc-epitope tag.
(A-C) The endogenous 140 kDa
isoform of palladin was detected with
the polyclonal antibody a-4IgNT. The
two isoforms strongly colocalize. Both
isoforms are detected periodically along
stress fibers (B and E) and both localize
to cell-cell junctions (C and F). Bars,
50 m.
Fig. 4. (A) Overexpression of
palladin isoforms in COS-7 cells
results in striking, but distinct,
actin organization phenotypes.
Low-magnification images of
COS-7 cells stained for F-actin
and exogenous palladin 24 hours
after transfection of the 90 kDa
or 140 kDa isoforms. The
overexpression of the 90 kDa
isoform results in the formation
of unusually robust actin-cables,
whereas overexpression of the
140 kDa isoform results in the
assembly of compacted star-like
F-actin arrays. In the merged
images, phalloidin staining is
shown in green and myc-epitope
staining is in red. Bars, 50 m.
(B) High-magnification images
of single cells from the same
fields. Bars, 50 m. (C) Bar
graph, indicating the differences
between phenotypes
overexpressing the 90 kDa and
140 kDa isoforms. For each
transfection, 100 cells were scored blindly and F-actin phenotypes were grouped into one of three classes: stars-like assemblies, large bundles
and small bundles (examples are given in supplementary material, Fig. S3). Overexpression of the 140 kDa isoform leads to more pronounced,












isoform, none formed compacted star-like assemblies, 57
formed large bundles and 43 formed small bundles (Fig. 4C).
These observations demonstrate first that both isoforms of
palladin have potent effects on F-actin organization when
expressed exogenously and, second that these two isoforms
possess functional differences that result in distinct
overexpression phenotypes.
A conserved poly-proline motif mediates the interaction
of 4IgC palladin with Lasp-1
Since the 140 kDa isoform of palladin contains an additional 339
amino acids at its N-terminus relative to the 90 kDa isoform, we
reasoned that it was likely to have additional binding partners
not shared with the smaller isoform. As shown in Fig. 5, the 140
kDa and 200 kDa isoforms of palladin contain a short sequence
motif that is shared with myopalladin. A proline triplet within
this sequence has previously been shown to mediate a direct
interaction between myopalladin and the SH3 domain of the
sarcomeric protein nebulin (Bang et al., 2001; Ma and Wang,
2002). To identify new proteins that might interact with this
motif, we undertook a database and literature search to identify
proteins with similar tissue-expression patterns that contain an
SH3 domain with a high degree of homology to that of nebulin.
We identified Lasp-1 as a protein that met these criteria. The SH3
domain of Lasp-1 is 80% identical and 86% conserved to that
of nebulin (Fig. 5B). Since Lasp-1 and the 140 kDa isoform of
palladin are both widely expressed, it seemed probable that the
two proteins could interact in vivo. To determine whether 140
kDa palladin binds directly to Lasp-1, a targeted yeast two-
hybrid assay was used. The coding sequences of 140 kDa and
90 kDa isoforms of palladin were cloned into GAL4-binding-
domain vectors (bait). In this assay, 90 kDa palladin was not
predicted to bind to Lasp-1 and functioned as a negative control.
The Lasp-1 coding sequence and the coding sequence of the
Lasp-1 SH3 domain were cloned into GAL4-activation-domain
vectors (prey). The ability of bait-and-prey fusion proteins to
interact with one another was assayed by observing growth and
galactosidase-dependent color change in co-transfected
colonies. As shown in Fig. 6A, yeast two-hybrid results indicate
that, as expected, Lasp-1 binds directly to the 140 kDa isoform
of palladin but not the 90 kDa isoform. Furthermore, the SH3
domain of Lasp-1 is sufficient for this interaction. To confirm
the exact binding site for Lasp-1 on the 140 kDa isoform, we
mutagenized two proline residues to alanines in the putative
SH3-binding motif. A similar mutation was shown to ablate the
interaction between myopalladin and nebulin (Bang et al., 2001).
In 140 kDa paladin, this mutation similarly disrupts its
interaction with Lasp-1. As expected, this mutation did not affect
the interaction of palladin with VASP, which binds to the distinct
proline-rich (FPPPP) motif. To confirm these results, we cloned
the Lasp-1 and SH3-domain sequences into a GST-fusion
expression construct. These two proteins were expressed,
purified from bacteria and used to pull-down endogenous
proteins from lysates of HeLa cells, a cell line that expresses
both the 90 kDa and 140 kDa palladin isoforms. The SH3
domain of Lasp-1 specifically pulled-down the 140 kDa isoform
but not the 90 kDa isoform of palladin from these cell lysates
(Fig. 6B), as does the full length Lasp-1 protein (data not shown).
Thus, we have identified Lasp-1 as an isoform-specific binding
partner for palladin.
Journal of Cell Science 119 (6)
Fig. 5. (A) Alignment of the sequence conserved between
myopalladin and palladin that mediates binding of the SH3 domain
of nebulin. The poly-proline motif responsible for the nebulin and
Lasp-1 interactions is indicated by an asterisk. (B) Alignment of the
SH3 domain of nebulin with the SH3 domain of Lasp-1. The core
SH3-domain sequence is 80% identical.
Fig. 6. (A) Yeast two-hybrid analysis of interaction of Lasp-1with palladin. (i) Schematic
representations of constructs used for the yeast two-hybrid analysis. (ii) The strength of the
interaction between bait and prey constructs, as indicated by cell growth and -galactosidase
activity was scaled from no interaction (–) to strong interaction (+++). Yeast two-hybrid
analysis indicates that Lasp-1 interacts through its SH3 domain with the poly-proline motif in the 140 kDa isoform, but not that in the 90 kDa
isoform. A mutation to the putative poly-proline motif abrogates this interaction in the 140 kDa isoform. (B) HeLa cells express both the 140
kDa and 90 kDa isoforms of palladin. The SH3 domain of Lasp-1 co-precipitates the 140 kDa palladin. GST protein or the GST domain fused
to the SH3 domain of Lasp-1 was incubated with HeLa-cell lysate and precipitated with glutathione Sepharose. Western blot analysis indicates
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Lasp-1 and 140 kDa palladin colocalize in stress fibers
and cell-cell-contacts of astrocytes
Lasp-1 has been shown to localize to F-actin and focal
adhesions in a variety of cell types, but its localization pattern
in astrocytes has not been explored previously. To determine
the degree of colocalization of Lasp-1 with endogenous 140
kDa palladin, double-label immunofluorescence staining of
cultured astrocytes was performed. Staining with a previously
characterized Lasp-1 antibody (Chew et al., 2000) indicates
that Lasp-1 is expressed in astrocytes and significantly
colocalizes with 140 kDa palladin. In short-term cultures, the
cells mainly assume a fibroblastic morphology, and Lasp-1
primarily localizes to stress fibers in a manner similar to
paladin (Fig. 7A-F). In cultures incubated for longer, both the
140 kDa isoform of palladin and Lasp-1 were observed to
colocalize in cell-cell-contacts of epithelial-like cells (Fig.
7G-I). These colocalization results support the idea that 140
kDa palladin and Lasp-1 form a stable molecular complex in
vivo. 
Silencing 140 kDa palladin results in the loss of Lasp-1
from stress-fibers in HeLa cells
Lasp-1 exhibits significant variability in its cellular
distribution. In different cell types, Lasp-1 may localize to
focal adhesions, stress fibers, dorsal ruffles and/or membrane
protrusions. In HeLa cells, Lasp-1 was detected in focal
adhesions and stress fibers (Fig. 8A), and 140 kDa palladin was
concentrated in stress fibers. To determine whether this
palladin isoform plays a role in recruiting Lasp-1 to stress
fibers, HeLa cells were transfected with small interference
RNA (siRNA) that silences the 140 kDa isoform but not the 90
kDa isoform of palladin (western blots are shown in
supplementary material Fig. S4). In cells where the 140 kDa
isoform has been silenced, Lasp-1 localizes to peripheral focal
Fig. 7. Localization of Lasp-1 and 140 kDa
palladin in astrocytes. The 140 kDa isoform
of palladin was detected with the polyclonal
4IgNT antibody characterized in Fig. 2, and
Lasp-1 was detected with the 3H8
monoclonal antibody. In the merged images,
palladin staining is shown in green and Lasp-
1 staining is shown in red. Both Lasp-1 and
the 140 kDa isoform of palladin colocalize in
stress fibers of astrocytes (A-F), although
Lasp-1 exhibits a more pronounced
localization to focal adhesions. In longer-term
cultures of astrocytes that have formed
monolayers of epithelial-like cells, both
palladin and Lasp-1 are detected within cell-
cell-contacts (G-I). Bars, 50 m.
Fig. 8. siRNA targeting of 140 kDa palladin
results in loss of Lasp-1 from stress fibers.
HeLa cells were transfected with either control
siRNA or palladin siRNA specific for 140 kDa
palladin. (A-C) Both 140 kDa palladin and
Lasp-1 are detected in stress fibers (controls).
Lasp-1 is also detected in peripheral adhesions.
(D-F) Loss of 140 kDa palladin from these
cells results in the loss of Lasp-1 recruitment
to stress fibers, although it is still strongly
detected in peripheral adhesions. When 140
kDa palladin is re-expressed in these cells by
transfection of a construct in which GFP is
conjugated to the 140 kDa isoform, Lasp-1 is
observed to regain its localization to stress
fibers (G-I). Higher magnification of Lasp-1
staining in these cells is provided in a, d, and












adhesions, but not to stress-fibers (Fig. 8D). This difference in
localization does not appear to be a secondary effect of actin
disruption because stress fibers remain relatively intact under
these conditions (Fig. 8F). Re-expression of GFP-140 kDa
palladin into the siRNA-treated cells resulted in the restoration
of Lasp-1 to stress fibers. These experiments demonstrate that
the expression of 140 kDa palladin modulates the localization
of Lasp-1 and, thus, may serve a role in regulating the function
of Lasp-1 within the cell.
Discussion
The actin-associated protein palladin has been shown
previously to exist as multiple-size variants in different tissues
(Parast and Otey, 2000; Hwang et al., 2001; Boukhelifa et al.,
2001; Mykkanen et al., 2001), but these earlier studies
provided no insight into the sequence of palladin isoforms and
how they are related to the common 90 kDa form. In this report,
we demonstrate that the palladin gene has a nested structure,
such that expression of each of the three major isoforms (200
kDa, 140 kDa and 90 kDa) is controlled by one of three
independent promoters. This new information on the palladin
gene suggests that control of isoform expression is likely to be
tightly regulated within cells, supporting the view that palladin
isoforms might contribute to cell morphology in unique ways.
Previously, palladin was shown to have a crucial role in
establishing specialized cell morphologies in neurons,
astrocytes, trophoblasts and dendritic cells (Parast and Otey,
2000; Mykkanen et al., 2001; Boukhelifa et al., 2001;
Boukhelifa et al., 2003). More recently, the creation of a
palladin-knockout mouse demonstrated the requirement for
palladin during mammalian embryogenesis. Loss of palladin
expression resulted in neural-tube-closure defects, ventral
herniation and embryonic lethality (Luo et al., 2005). Palladin
might also serve an important function in the human vascular
system, because a single nucleotide polymorphism in the
human palladin gene has been found to be associated with
increased risk for myocardial infarction (Shiffman et al., 2005).
The importance of palladin for cell morphology, motility and
contractility is supported by the observation that the two most
common palladin isoforms uniquely organize F-actin into
bundled arrays. It remains to be determined whether this effect
is due to an actin-crosslinking activity, enhanced actin-myosin
contractility and/or effects on actin polymerization. In this
report, we also show that palladin isoforms participate in distinct
biochemical pathways because the 140 kDa isoform of palladin
binds to Lasp-1, a molecular partner that is not shared with the
more abundant 90 kDa form of palladin. The functional
significance of this interaction remains to be determined because
the precise molecular function of Lasp-1 is still unknown.
Lasp-1 is a protein with complex localization patterns. In
general, Lasp-1 is associated with sites of dynamic cytoskeletal
reorganization. In hippocampal neurons, Lasp-1 is
concentrated in growth cones and dendritic spines, which are
motile structures (Phillips et al., 2004). In cultured fibroblasts,
Lasp-1 is detected in focal adhesions and at the leading edge
of lamellipodia and the tips of filopodia (Chew et al., 2002).
Its localization pattern is variable and depends, in part, upon
growth factor stimulation and the activation of specific protein
kinase pathways. In gastric mucosal fibroblasts, Lasp-1 is
recruited from focal adhesions to the leading edge of
lamellipodial protrusions by treatment with the phorbol ester
phorbol 12-myristate 13-acetate (PMA) (Chew et al., 2002). In
fibroblasts, Lasp-1 translocates from the cell periphery to focal
adhesions following treatment with growth factors that
stimulate cell motility; downregulation of Lasp-1 results in
cells failing to migrate (Lin et al., 2004). In cultured epithelial
cells, phosphorylation of Lasp-1 appears to trigger its
redistribution from focal contacts to the cytosol, with a
concomitant reduction in cell migration (Keicher et al., 2004).
Together, these results demonstrate the importance of
identifying the molecular binding partners that interact with
Lasp-1 in different subcellular locations, in order to gain
insight into the molecular pathways that regulate cell motility
and adhesion. The effects of Lasp-1 on actin organization
might be mediated directly, because Lasp-1 binds to
filamentous actin (Chew et al., 2002). However, the multi-
domain-organization of Lasp-1 suggests that it also functions
as a scaffold to recruit components of signaling pathways to
the actin cytoskeleton. The binding of Lasp-1 to palladin,
another multi-domain protein, is suggestive of a hierarchy of
scaffolds binding to scaffolds, thus, highlighting the
complexity of the pathways that control actin dynamics.
Analysis of the molecular partners of Lasp-1 and palladin
reveals an interesting degree of apparent redundancy in these
pathways. Lasp-1 binds to another actin-associated scaffold,
zyxin, which binds to both VASP family members and -
actinin (Crawford et al., 1992; Reinhard et al., 1995; Drees et
al., 2000; Li et al., 2004). Since palladin also binds to Lasp-1,
VASP and -actinin (Boukhelifa et al., 2004; Ronty et al.,
2004), it appears that palladin and zyxin probably share some
degree of overlap in their cellular functions. However, because
zyxin and palladin both interact with the SH3 domain of Lasp-
1, it is possible that these two proteins compete for binding to
Lasp-1 and this might also play a role in regulating the
localization and function of Lasp-1.
Lasp-1 was identified as a binding partner for palladin by
virtue of its homology with the SH3 domain of nebulin. Bang
and co-workers demonstrated that myopalladin, a palladin
homologue, binds directly to nebulin through its SH3 domain
(Bang et al., 2001). This strongly suggests that, the 140 kDa
and 200 kDa isoforms of palladin can also bind to nebulin in
skeletal muscle and nebulette in cardiac muscle through the
conserved polyproline sequence that is shared with
myopalladin. Therefore, probably a significant functional
overlap exists between myopalladin and palladin in these
tissues. Palladin might also interact with newly characterized
protein Lasp-2 and Lim-nebulette (Terasaki et al., 2004; Li et
al., 2004), which share the conserved SH3 domain.
To date, all of the molecular partners identified for palladin
bind to either monomeric or filamentous actin. Thus, these latest
results support the hypothesis that palladin functions as a highly
potent scaffolding molecule, with the potential to influence both
actin polymerization and the assembly of existing actin
filaments into bundles and other higher-order arrays.
Materials and Methods
Identification and cloning of palladin isoforms
The mouse cDNA databases (GenBank) were compared by using BLAST with
previously published palladin sequences using the ‘nonredundant’ program of the
National Center for Biotechnology Information (NCBI). This initial search for
palladin cDNAs revealed the existence of several new clones that could code for
alternative isoforms. Full-length sequences were corroborated in BLAST by using
the expressed sequence tag (EST) databases with isoform specific sequences,
namely the 5 untranslated regions (5 UTRs). The organization of the murine
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palladin gene was determined by blasting all palladin cDNA sequences against the
genomic database. The three putative promoters of paladin were identified by
comparing the 5 UTR of identified transcripts with the genomic sequence. 
Several full-length clones encoding the 140 kDa four-IgC2-domain isoform were
identified (GenBank accession numbers AK03196, AK173081 and 4947562). First-
strand cDNA corresponding to the coding sequence of the 140 kDa isoform was
polymerized from cultured embryonic astrocyte mRNA with the gene-specific
primer TCAAAATCCTAAATTGGGGCTGTT and Superscript III reverse
transcriptase (Invitrogen). The coding sequence of 140 kDa isoform was PCR-
amplified with Pfu-Ultra (Stratagene), the above primer and the forward primer
ATGCCACAAGCTCAGAAGAAA. This sequence was cloned into the mammalian
expression vector pRK5-MYC for myc-epitope-tagged protein expression.
Isoform-selective palladin polyclonal antibody
The N-terminal sequence of the 140 kDa isoform not found within the 90 kDa
isoform was cloned into a GST-expression vector (pGEX-4T-1 4IgNT, Amersham).
cDNA was amplified with the forward primer GTCGACCACAAGCTCAGAAG-
AAAACAACGT and the reverse primer GCGGCCGCAAATCCTAAATTGGG-
GCT. The PCR product was cloned into SalI and NotI sites of pGEX-4T-1.
BL21(DE3)pLysS bacteria (Stratagene) were transformed and the protein was
expressed following induction with isopropyl-beta-D-thiogalactopyranoside
(IPTG). The fusion protein was purified with glutathione-Sepharose (Amersham)
and eluted with bovine thrombin (Sigma). Two rabbits were immunized with the
purified eluate. The antibody was affinity-purified with the GST-4IgNT protein
crosslinked to cyanogen-bromide-activated Sepharose. This antibody has been
designated a-4IgNT.
Western blots
Tissues from neonatal mice (postnatal day one) were freshly dissected, immediately
frozen in liquid nitrogen, ground to a fine power with mortar and pestle and
solubilized in lysis buffer (50 mM Tris-buffered saline pH 7.0, with 4 M urea, 2%
SDS, 10 mM EDTA and protease inhibitor cocktail for mammalian tissue extracts,
Sigma Aldrich). Lysates were boiled with 2 Laemmli buffer. Per lane, 10 m of
protein were resolved by SDS-PAGE on a 4-12% polyacrylamide gel, then
immunoblotted. The larger 140 kDa and 200 kDa isoforms were detected with the
a-4IgNT polyclonal antibody. For immunoblotting of astrocytes, cultures were
prepared by the method previously described (Boukhelifa et al., 2003). Astrocytes
were lysed after a 1 week incubation by scraping cells into 50 mM Tris pH 7.0 with
150 mM NaCl, 10 mM EDTA, 1% deoxycholate, 1% NP-40 and a protease inhibitor
cocktail for mammalian tissues (Sigma). The 90 kDa isoform was detected with the
previously characterized 1E6 monoclonal antibody (Parast and Otey, 2000). For
imaging, secondary antibodies conjugated to either IRdye700 or 800 (Rockland)
were used with the Odyssey infrared imaging system (Licor). 
Yeast two-hybrid assay
The coding sequence of 140 kDa palladin isoform was cloned into the GAL4 DNA-
binding domain (bait) vector  (pGBKT7; Clontech) with forward and reverse
primers CATATGCCACAAGCTCAGAAGAA and GTCGACTCACAGGTCTT-
CACTTTCTAC, respectively. The Lasp-1-binding poly-proline motif was mutated
(P264A; P266A) with the Quickchange site-directed mutagenesis kit (Stratagene),
with primers CACCCACTAAGGAAGCACCGGCACTCCTTGCCAAAC and
GTTTGGCAAGGAGTGCCGGTGCTTCCTTAGTGGGTG. The full-length Lasp-
1-coding sequence and the sequence corresponding to the SH3 domain of Lasp-1
were PCR-amplified from a Lasp-1 cDNA clone (GenBank accession number
BC010840) and ligated into the  GAL4 activation-domain (prey) vector (pGADT7;
Clontech). The primer pairs CATATGAACCCTAACTGTGCCCGGT and
GAATTCTCAGATGGCCTCCACGTAGTT, and CATATGTCCATACAGCGC-
AGTGCC and GAATTCTCAGATGGCCTCCACGTAGTT, respectively, were used
for the Lasp-1 constructs. A GAL4-AD fusion of VASP in the pACT2 vector was
used as a positive control (provided by Frank Gertler, M.I.T. Boston, MA). The
AH109 yeast strain was transfected with the  bait and prey vectors using the Li/PEG
transfection protocol (Clontech). The transfected yeast cells were first grown on
minimal synthetic defined (SD)-Leu-Trp medium (Clontech) agar plates to select
for the pGBKT7 and pGADT7 vectors. After 3 days of growth at 30°C, colonies
were picked from each plate, resuspended and re-plated on minimal SD-Leu-Trp-
His-Ade medium (Clontech) agar plates supplemented with 20 g/ml X-Gal
(Clontech) and 7.5 mM 3-amino-1,2,4-triazole (3AT; Sigma). Yeast cells were
incubated for 7 days, at which time -galactosidase reporter activity had peaked.
The strength of the interaction was gauged by comparing changes in growth and
color with the provided positive control.
GST-pull-down assay
The Lasp-1-coding sequence was PCR-amplified with primers GAATTCATGA-
ACCCTAACTGTGCCCGGT and CTCGAGTCAGATGGCCTCCACGTAGTT.
The SH3 domain coding sequence was PCR-amplified with primers GAATTC-
TCCATACAGCGCAGTGCC and CTCGAGTCAGATGGCCTCCACGTAGTT.
Both sequences were cloned into the EcoRI and XhoI sites of GST-fusion expression
vector pGEX-4T-1 (Amersham). BL21 pLysS DE3 cells were transformed with
these plasmids. Expression was induced with IPTG. The proteins were purified with
glutathione-Sepharose beads (Amersham).
HeLa cells were grown in Dulbecco’s modified Eagle’s medium (DMEM; Gibco-
BRL) supplemented with 10% fetal bovine serum (FBS) and penicillin-
streptomycin-amphotecerin B. Confluent (70%) cultures were lysed with 1% Triton
X-100 in 50 mM Tris pH 7.4 containing 10 mM EDTA and a protease inhibitor
cocktail for mammalian tissues (Sigma). Lysates were centrifuged at 100,000 g for
30 minutes. GST or GST-SH3 protein (10 g), which had been crosslinked to
cyanogen bromide activated sepharose (Sigma) was added to the supernatant and
allowed to incubate for 1 hour. The beads were centrifuged and washed four times
in lysis buffer. The bound fraction was eluted by boiling in 2 Laemmli buffer.
Samples were resolved by SDS-PAGE on a 4-12% gel, transferred to nitrocellulose
and blotted for palladin with the previously described monoclonal antibody 1E6
(Parast and Otey, 2000). The blot was developed with IRdye700-conjugated anti-
mouse IgG secondary antibody (Rockland) and imaged with the Odyssey infrared
imaging system (Licor).
Cell culture, transfection and immunofluorescence
Astrocytes were prepared from embryonic day 18 rats as previously described
(Boukhelifa et al., 2003). Cells were cultured for 1 week before fixing and
immunofluorescence staining. Extended cultures of astrocytes that form
epithelial-like monolayers were prepared by allowing the cells to grow for an
additional 2 weeks in DMEM supplemented with 10% FBS. These cells stained
positively for the intermediate filament protein GFAP, indicating that they were
astrocytes and not of vascular origin. For colocalization studies of the 90 kDa
and 140 kDa isoforms, astrocytes were infected for 12 hours with adenovirus
expressing the 90 kDa sequence with an N-terminal myc-epitope tag (107
PFU/ml). This virus was engineered by cloning the 90 kDa sequence into the
pVQ CMV K-NpA shuttle vector (Viraquest). Virus was produced as previously
described (Parast and Otey, 2000). Cells were fixed in 3.7% formaldehyde in PBS
with 5 mM CaCl2 and 5 mM MgCl2 for 5 minutes. Cells were permeabilized with
0.2 % Triton X-100 for 2 minutes and stained for the myc-epitope with the 9E10
monoclonal antibody (Sigma), for Lasp-1 with the previously characterized 3H8
monoclonal antibody (provided by Catherine Chew, Medical College of Augusta,
Augusta, CA), and/or for the 140 kDa isoform of palladin with the a-4IgNT
rabbit polyclonal antibody. Primary antibodies were detected with Alexa Fluor
488 and Alexa Fluor 568 anti-mouse IgG and anti-rabbit IgG conjugates
(Molecular Probes). Coverslips were examined with a Nikon TE200-U
microscope with 20 and 60 objectives, an optional 1.5 tube lens and a
Hamamatsu Orca-ER camera. Images were processed using Adobe Photoshop
7.0 (Adobe Systems Inc).
For overexpression experiments in COS-7 cells, cells were grown to 70%
confluency on glass coverslips in DMEM with 10% FBS and transfected with
pRK5-myc 90 kDa and 140 kDa vectors using Effectene reagent (Qiagen). Cells
were fixed 24 hours after transfection and stained for F-actin with Alexa-Fluor-488-
phallodin (Molecular Probes) and for exogenous palladin with 9E10 anti-myc and
Alexa Fluor 568 anti-mouse IgG.
For HeLa siRNA experiments, a 70% confluent culture of cells grown in DMEM
with 10% FBS was transfected with a final concentration of 50 nM 140 kDa palladin
specific siRNA duplex (GGCAAAGCUAACAGUAAUAdTdT, dTdTCCGUUU-
CGAUUGUCAUUAU; Dharmacon) or a control siRNA duplex (control X;
Dharmacon), which was transfected using TransIT siQuest (Mirus Bio). The cells
were trypsinized and seeded onto fibronectin-coated coverslips 8 hours after
transfection (bovine, 25ug/ml; Sigma Aldrich). The cells were fixed 72 hours after
transfection. For the rescue experiments, cells were seeded onto fibronectin-coated
coverslips and transfected with nontargeted murine pEGFP-140 kDa palladin using
TransIT-LT1 (Mirus Bio) 2 days after the initial siRNA transfection. The cells were
allowed to incubate for 16 hours before they were fixed in paraformaldehyde. All
coverslips were stained for Lasp-1 and 140 kDa palladin as described above. F-actin
was visualized with Alexa-Fluor-350-phalloidin (Molecular Probes). Images were
processed as described above.
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